<DOC>
	<DOCNO>NCT02054637</DOCNO>
	<brief_summary>Somatostatine induces dose-dependent reduction postprandial plasma cholecystokinin ( CCK ) secretion concomitant inhibition postprandial gallbladder contraction , abolish almost completely bile salt output gallbladder . Somatostatine also know decrease acid production significant increase intragastric pH . In way , somatostatine could influence acid well non-acid reflux decrease gallbladder empty decrease acid secretion . Purpose study evaluate efficacy lanreotide autogel 120 mg symptom endoscopic lesion patient endoscopic gastrointestinal reflux esophagitis control classic therapy .</brief_summary>
	<brief_title>Resolving Bile Reflux Lanreotide Patients With Roux-en-Y Gastrojejunostomy</brief_title>
	<detailed_description>Patients present persistent esophagitis endoscopy proton pump inhibitor ( PPI ) treatment receive maximal therapy consist 2 x 40 mg PPI meal ( morning evening ) H2 blocker bedtime ( standard practice ) . They reevaluate endoscopically clinically 2 month later ( standard practice ) . If reflux persists , objectivized impedancemetry ( standard practice ) , ask participate study . Lanreotide autogel 120 mg deep subcutaneously every 4 week add treatment . A total 3 injection per patient foreseen proof concept study . Patients reevaluate clinically 2 , 4 8 week . At end study new upper gastrointestinal endoscopy impedancemetry perform .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Esophagitis , Peptic</mesh_term>
	<mesh_term>Bile Reflux</mesh_term>
	<mesh_term>Lanreotide</mesh_term>
	<mesh_term>Angiopeptin</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<criteria>Persistent endoscopic reflux spite maximal medical therapy PPI 2 x 40 mg ( breakfast dinner ) 300 mg H2 blocker ranitidine ( bedtime ) . The Los Angeles classification ( LA ) use evaluate endoscopic reflux . Any distal esophageal ulcer negative biopsy also diagnostic reflux . Persistent reflux define : No reflux complaint continue endoscopic lesion positive impedancemetry . Reflux complaint continue endoscopic lesion positive impedancemetry . Reflux complaint without endoscopic lesion positive impedancemetry . Pregnancy inadequate anticonception , breast feeding . Negative impedancemetry . Diabetes . Placement gastric ring weight loss .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Bile reflux</keyword>
	<keyword>Reflux esophagitis</keyword>
	<keyword>Lanreotide autogel</keyword>
	<keyword>Somatuline</keyword>
	<keyword>Endoscopy</keyword>
	<keyword>Impedancemetry</keyword>
</DOC>